Clinical Trials

Foldax announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering. In a trial based in India, the mitral valve...

STENTiT, a pioneering medical device company, developing a novel class of stents with regenerative properties, today announced the successful implantation of its Resorbable Fibrillated...

Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device...

A new study has demonstrated proof of concept for a Biolinq continuous sensor in preventing muscle loss during GLP-1 therapy. Investigators presented findings as a...

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System for...

FineHeart announced French regulators gave it the green light to initiate a first-in-human heart device trial in France. The French National Agency for the Safety...

NeuroPace announced preliminary one-year results from its Nautilus clinical study evaluating neuromodulation therapy for idiopathic generalised epilepsy (IGE). The company said the study met its...

Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface technology. The company evaluated the safety and feasibility of...

EnVVeno Medical announced three-year outcomes for its heart valve that it aims to submit to the FDA this year. The company (formerly Hancock Jaffe)...